A. Alfred Taubman Medical Research Institute - where scientists create cures. University of Michigan Health System
An Evening of Art & Science - May 22
Unique fundraiser at MOCAD to auction works by area artists
based on Taubman Scholars' medical research
Click for event details and ticket information >
Institute to host Emerging Scholars Symposium April 30
Morning of science will showcase work of
young clinician-scientists
Taubman Science
11 Taubman Scholars named to "Best Doctors in America" list
They're among 493 U-M physicians to receive the honor from their peers
Click here for the list.
Taubman Science
Renowned diabetes expert to speak at U-M
David M. Nathan, M.D., of Harvard University to deliver two lectures April 18
Click here for details
Taubman Science
U-M offers new early detection prostate cancer test
Research by Taubman Scholar Dr. Arul Chinnaiyan has let to the development of a new test for prostate cancer that is far more accurate than the standard PSA test, the University of Michigan has announced.
Click here to read more.
news & events
The Latest
Taubman Science
New Taubman Prize trophy debuts
The new trophy for the Taubman Prize for Excellence in Translational Medical Research, which was designed in consultation with institute founder Mr. A. Alfred Taubman, was presented at the institute's Oct. 11 symposium. The modern sculpture was created using a novel 3D printing technique.
Taubman Science
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Taubman Science
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.
Discovery-driven research that matters
Taubman Scholar Dr. Charles Burant tests promising diabetes drugTAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study. |
Taubman Institute leaders make the case for more doctor-scientist funding
The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts. The article explores the problematic gap between bench research and clinical application of new treatments or cures. |
Help Us Make A Difference. Make A Gift.
Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.
Meet the Leadership Advisory Board
Meet the Scientific Advisory Board
Links that may be of further interest...
|
Program for Neurology Research & Discovery Consortium for Stem Cell Therapies |
|
About Taubman Institute Video
In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.
Stem cell surgery targets ALS Video
Patients glean hope from trial’s progress but wish it were faster
Donors pitch in to keep brilliant science minds at U-M Video
Emerging Scholars program connects promising M.D.-researchers with philanthropists
